Does Total Implantability Reduce Infection With the Use of a Left Ventricular Assist Device? The LionHeart Experience in Europe

Pae, Walter E.; Connell, John; Adelowo, Amos; Boehmer, John; Körfer, Reiner; El‐Banayosy, Aly; Hetzer, Roland; Viganò, Mario; Pavie, Alain

doi:10.1016/j.healun.2006.12.007

Cited by 104 publications

(55 citation statements)

References 41 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The LionHeart LVAD was a unique LVAD system that employed a transcutaneous energy conduction system to allow full implantability. While this system eliminated driveline infectious risk, other complications remained or increased [39].…”

Section: Other Vadsmentioning

confidence: 99%

Current Options and Practices in Long-Term Ventricular Assist Devices

2014

View full text Add to dashboard Cite

End-stage heart failure poses a significant problem for patients and a burden on the healthcare system. With a lack of available hearts for transplant, mechanical circulatory support has emerged as a viable treatment option. The first generation ventricular assist device (VAD) showed superior outcomes to optimal medical management. Now with second and third generation continuous-flow VADs available, outcomes have continued to improve. Patients who undergo VAD implantation have superior survival and increased quality of life; however, they also have a significant risk of adverse events. These adverse events are decreasing as newer devices are developed, surgical experience increases, postoperative care improves and patient selection trends toward less critically ill patients. Future progress of the VAD will continue to improve survival and decrease adverse events.

show abstract

Section: Other Vadsmentioning

confidence: 99%

Current Options and Practices in Long-Term Ventricular Assist Devices

2014

View full text Add to dashboard Cite

show abstract

“…Among the ultimate goals is total implantability of the VAD which would eliminate the need for a driveline and thereby eliminate one of the most important pathways for infection . The clinical utility baseline study (CUBS) trial from 2007 compared the totally implantable LionHeart to the REMATCH data and demonstrated decreased incidence of infection with the totally implantable device suggesting that total implantability may improve infectious outcomes after VAD (Pae et al, 2007) …”

Section: Future Implicationsmentioning

confidence: 99%

Ventricular Assist Device-Specific Infections

Pauwaa¹,

Bhat²

2011

Ventricular Assist Devices

View full text Add to dashboard Cite

“…There was also a 9% decrease in device-site infections and a 100% decrease in pump-housing and pump inflow-and outflow-tract infections. 16) As of July 2006, a total of 26 patients had been implanted with the Arrow LionHeart MCSD. Fig.…”

Section: )mentioning

confidence: 99%

Current Mechanical Circulatory Support Devices for End Stage Heart Failure

Park

2009

Korean Circ J

View full text Add to dashboard Cite

Mechanical circulatory support is necessary when heart failure becomes refractory to medical support. It is typically instituted when organ dysfunction occurs as a result of hypoperfusion. Enthusiasm has recently developed for the role of mechanical circulatory support in the ever-growing population of heart failure patients. Indeed, efforts in developing this technology have allowed for the relatively recent development of a variety of complete circulatory support devices. The use of left ventricular assist devices (LVADs) in patients with advanced heart failure results in a clinically meaningful survival benefit and an improved quality of life, and LVADs could be an acceptable alternative therapy for selected patients who are not candidates for cardiac transplantation.

show abstract

Does Total Implantability Reduce Infection With the Use of a Left Ventricular Assist Device? The LionHeart Experience in Europe

Cited by 104 publications

References 41 publications

Current Options and Practices in Long-Term Ventricular Assist Devices

Current Options and Practices in Long-Term Ventricular Assist Devices

Ventricular Assist Device-Specific Infections

Current Mechanical Circulatory Support Devices for End Stage Heart Failure

Contact Info

Product

Resources

About